Essential Reads: Topiramate and Pregnancy (2021)
Multiple studies have associated first trimester exposure to topiramate with increased risk of oral clefts.
Multiple studies have associated first trimester exposure to topiramate with increased risk of oral clefts.
Parenting support, maternal bonding with the infant, engagement in an OUD treatment program, and recovery-specific support systems promoted recovery in postpartum women with opioid use disorders.
Screening, Brief Intervention and Referral to Treatment or SBIRT has been shown to be a quick and effective means of identifying and intervening with patients whose patterns of use put them at risk for, or who already have, substance-related health problems.
This article focuses on how GABA-ergic neurotransmitter systems may modulate the interaction between reproductive steroid and sex steroid systems, and sheds light on the role allopregnanolone may play in medicating vulnerability to depression.Â
In studies of psychosis unrelated to childbirth, there is evidence linking stress to the onset of psychosis.Â
Research has also identified an increased risk of disordered eating symptoms in the perinatal period even among women without an eating disorder diagnosis, yet gaps exist in our knowledge pertaining to the association between psychosocial risk factors and disordered eating in this population.
Every week we review the most recent publications in women’s mental health, covering topics related to premenstrual symptoms, perinatal mood and anxiety disorders, use of medications in pregnant and breastfeeding women, perinatal substance [...]
Because postpartum psychosis is relatively uncommon, we do not have as much information on this illness as we have on postpartum depression. Â In addition, most of the literature we have on postpartum psychosis is not [...]
Women may experience depression and post-traumatic symptoms, especially those who were separated from their newborns after delivery and those with severe COVID-19 illness during pregnancy or after delivery.Â
In an evidence-based review published in 2012, Laura Wakil, Samantha Meltzer-Brody, and Susan Girdler present a thorough review of premenstrual dysphoric disorder (PMDD), reviewing its diagnosis and treatment options.